Management of chronic heart failure guided by individual N-terminal ProB-type natriuretic peptide targets: Results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) Study

Journal of the American College of Cardiology

Volumn 56, Issue 25, 2010, Pages 2090-2100

  Eurlings, Luc W M ^a   Van Pol, Petra E J ^b   Kok, Wouter E ^c   Van Wijk, Sandra ^a   Lodewijks Van Der Bolt, Cara ^d   Balk, Aggie H M M ^e   Lok, Dirk J A ^f   Crijns, Harry J G M ^a   Van Kraaij, Dave J W ^d   De Jonge, Nicolaas ^g   Meeder, Joan G ^h   Prins, Martin ^a   Pinto, Yigal M ^c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b REINIER DE GRAAF HOSPITAL   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d Sittard Geleen Heerlen   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f AHS Deventer   (Netherlands)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^h VIECURI MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG TARGETING; FEMALE; HEART FAILURE; HOSPITAL DISCHARGE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PATIENT CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ALDOSTERONE ANTAGONISTS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-ARRHYTHMIA AGENTS; BIOMARKERS, PHARMACOLOGICAL; DIGOXIN; DIURETICS; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES;

EID: 78650019808     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.07.030     Document Type: Article

References (20)

1. J.L. Januzzi, R. van Kimmenade, and J. Lainchbury NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study Eur Heart J 27 2006 330 337
2. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
3. J.A. Doust, E. Pietrzak, A. Dobson, and P. Glasziou How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review BMJ 330 2005 625
4. F. Hartmann, M. Packer, and A.J. Coats Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial Circulation 110 2004 1780 1786
5. R.W. Troughton, C.M. Frampton, T.G. Yandle, E.A. Espiner, M.G. Nicholls, and A.M. Richards Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations Lancet 355 2000 1126 1130
6. J.G. Lainchbury, R.W. Troughton, and K.M. Strangman N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial J Am Coll Cardiol 55 2009 53 60
7. M. Pfisterer, P. Buser, and H. Rickli BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial JAMA 301 2009 383 392
8. P. Jourdain, G. Jondeau, and F. Funck Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study J Am Coll Cardiol 49 2007 1733 1739
9. M.S. Nieminen, M. Bohm, and M.R. Cowie Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology Eur Heart J 26 2005 384 416 (Pubitemid 40283098)
10. K. Swedberg, J. Cleland, and H. Dargie Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology Eur Heart J 26 2005 1115 1140
11. T.S. Rector, S.H. Kubo, and J.N. Cohn Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo Am J Cardiol 71 1993 1106 1107
12. A. Maisel Natriuretic peptide-guided therapy for heart failure: ready for "battle" or too "scarred" by the challenges of trial design? J Am Coll Cardiol 55 2009 61 64
13. P.A. McCullough, and K.R. Sandberg Sorting out the evidence on natriuretic peptides Rev Cardiovasc Med 4 Suppl 4 2003 S13 S19
14. M.J. Lenzen, E. Boersma, and W.J. Reimer Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure Eur Heart J 26 2005 2706 2713
15. D.R. Murdoch, T.A. McDonagh, and J. Byrne Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy Am Heart J 138 1999 1126 1132
16. M. Yoshimura, Y. Mizuno, and M. Nakayama B-type natriuretic peptide as a marker of the effects of enalapril in patients with heart failure Am J Med 112 2002 716 720
17. C. Zugck, A. Haunstetter, and C. Kruger Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure J Am Coll Cardiol 39 2002 1615 1622
18. M.S. Nieminen, D. Brutsaert, and K. Dickstein EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population Eur Heart J 27 2006 2725 2736
19. A. Bayes-Genis, D. Pascual-Figal, and J. Fabregat Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure Int J Cardiol 120 2007 338 343
20. R.J. O'Brien, I.B. Squire, B. Demme, J.E. Davies, and L.L. Ng Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF Eur J Heart Fail 5 2003 499 506